Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2018

Open Access 01-12-2018 | Research

Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients

Authors: Francesca Marini, Francesca Giusti, Maria Luisa Brandi

Published in: Orphanet Journal of Rare Diseases | Issue 1/2018

Login to get access

Abstract

Background

Multiple endocrine neoplasia (MEN1) is a rare inherited multi-tumour syndrome, affecting specific neuroendocrine organs and non-endocrine tissues with a variable spectrum of over 20 possible different combinations, caused by inactivating heterozygote mutations of the MEN1 gene.
Disease onset, penetrance, clinical presentation, course and prognosis are all extremely variable, even among individuals bearing the same causative mutation, which doesn’t allow prediction of the individual clinical phenotype (based on the specific result of the genetic test), thus compelling all patients and mutation carriers to undergo a common routine general screening program.

Results

We performed an extensive epidemiological, clinical and genetic analysis of the Florentine MEN1 patient database, which includes 145 MEN1 patients and 20 asymptomatic MEN1 carriers, constantly followed up at the Regional Referral Centre for Inherited Endocrine Tumours of the Tuscany Region, during the last three decades. We reported, here, the results of clinical, epidemiological and genetic descriptive statistics, as well as correlation analyses between tumours and mutation types and localisation. No direct genotype-phenotype correlation was described, but the importance of the genetic testing was confirmed for an early diagnosis and the identification of asymptomatic carriers.

Conclusions

As with all rare diseases, the possibility to collect and analyse data on a relatively large number of patients is important for increasing our knowledge of the epidemiologic aspects of the disease, and its natural course and prognosis of single manifestations of the syndrome, in order to set up the best diagnostic and therapeutic plans for patients. In this light, the creation and constant updating of large patient databases is fundamental. Results from database study can provide useful epidemiological, clinical and genetic information about MEN1 syndrome, which could help clinicians in the diagnostic and therapeutic management of single MEN1 patients.
Literature
1.
go back to reference Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011.CrossRef Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011.CrossRef
2.
go back to reference Giusti F, Cianferotti L, Gronchi G, Cioppi F, Masi L, Faggiano A, et al. Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1). Endocrine. 2016;52:495–506.CrossRef Giusti F, Cianferotti L, Gronchi G, Cioppi F, Masi L, Faggiano A, et al. Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1). Endocrine. 2016;52:495–506.CrossRef
3.
go back to reference Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29(1):22–32.CrossRef Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat. 2008;29(1):22–32.CrossRef
4.
go back to reference Concolino P, Costella A, Capoluongo E. Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years. Cancer Genet. 2016;209(1–2):36–41.CrossRef Concolino P, Costella A, Capoluongo E. Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years. Cancer Genet. 2016;209(1–2):36–41.CrossRef
5.
go back to reference Marini F, Carbonell Sala S, Falchetti A, Caramelli D, Brandi ML. The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis. J Endocrinol Investig. 2008;31(10):905–9.CrossRef Marini F, Carbonell Sala S, Falchetti A, Caramelli D, Brandi ML. The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis. J Endocrinol Investig. 2008;31(10):905–9.CrossRef
6.
go back to reference Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol. 2012;76:533–9.CrossRef Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol. 2012;76:533–9.CrossRef
7.
go back to reference Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017;58:349–59.CrossRef Giusti F, Cianferotti L, Boaretto F, Cetani F, Cioppi F, Colao A, et al. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database. Endocrine. 2017;58:349–59.CrossRef
8.
go back to reference de Laat JM, Dekkers OM, Oieternab RC, Kluijfhout WP, AdR H, Pereira AM, et al. Long-term natural course of pituitary tumors in patients with MEN1: results from the dutchMEN1 study group (DMSG). J Clin Endocrinol Metab. 2015;100(9):3288–96.CrossRef de Laat JM, Dekkers OM, Oieternab RC, Kluijfhout WP, AdR H, Pereira AM, et al. Long-term natural course of pituitary tumors in patients with MEN1: results from the dutchMEN1 study group (DMSG). J Clin Endocrinol Metab. 2015;100(9):3288–96.CrossRef
9.
go back to reference Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Ménégaux F, et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs endocrines. Eur J Endocrinol. 2011;165(1):97–105.CrossRef Goudet P, Bonithon-Kopp C, Murat A, Ruszniewski P, Niccoli P, Ménégaux F, et al. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs endocrines. Eur J Endocrinol. 2011;165(1):97–105.CrossRef
10.
go back to reference Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, et al. Groupe d'études des Tumeurs endocrines. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol. 2008;32(4):534–43.CrossRef Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, et al. Groupe d'études des Tumeurs endocrines. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol. 2008;32(4):534–43.CrossRef
11.
go back to reference Pieterman CRC, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, et al. Primary hyperparathyroidism in MEN1 patients. A cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012;255(6):1171–8.CrossRef Pieterman CRC, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, et al. Primary hyperparathyroidism in MEN1 patients. A cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012;255(6):1171–8.CrossRef
12.
go back to reference Conemans EB, Nell S, Pieterman CRC, de Herder WW, Dekkers OM, Hermus AR, et al. Prognostic factors for survival of MEN1 patients with duodenopancreatic tumors metastatic to liver: results from the DMSG. Endocr Pract. 2017;23(6):641–8.CrossRef Conemans EB, Nell S, Pieterman CRC, de Herder WW, Dekkers OM, Hermus AR, et al. Prognostic factors for survival of MEN1 patients with duodenopancreatic tumors metastatic to liver: results from the DMSG. Endocr Pract. 2017;23(6):641–8.CrossRef
13.
go back to reference Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249–55.CrossRef Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249–55.CrossRef
14.
go back to reference Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, et al. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg. 2006;243(2):265–72.CrossRef Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, et al. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg. 2006;243(2):265–72.CrossRef
15.
go back to reference Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Lévy-Bohbot N, et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs endocrines. J Clin Endocrinol Metab. 2015;100(4):1568–77.CrossRef Goudet P, Dalac A, Le Bras M, Cardot-Bauters C, Niccoli P, Lévy-Bohbot N, et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs endocrines. J Clin Endocrinol Metab. 2015;100(4):1568–77.CrossRef
16.
go back to reference Vannucci L, Marini F, Giusti F, Ciuffi S, Tonelli F, Brandi ML. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors. Endocrine. 2018;59(2):438–48.CrossRef Vannucci L, Marini F, Giusti F, Ciuffi S, Tonelli F, Brandi ML. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors. Endocrine. 2018;59(2):438–48.CrossRef
17.
go back to reference Lips CJ, Dreijerink KM, Hoppener JW. Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation. Clinics. 2012;67:49–56.CrossRef Lips CJ, Dreijerink KM, Hoppener JW. Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation. Clinics. 2012;67:49–56.CrossRef
18.
go back to reference Marini F, Giusti F, Fossi C, Cioppi F, Cianferotti L, Masi L, et al. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. Endocrine. 2018;62(1):215–33.CrossRef Marini F, Giusti F, Fossi C, Cioppi F, Cianferotti L, Masi L, et al. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. Endocrine. 2018;62(1):215–33.CrossRef
19.
go back to reference Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, et al. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’étude des Tumeurs endocrines (GTE) cohort study. Hum Mol Genet. 2013;22(10):1940–8.CrossRef Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Murat A, et al. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d’étude des Tumeurs endocrines (GTE) cohort study. Hum Mol Genet. 2013;22(10):1940–8.CrossRef
20.
go back to reference Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Le Bras M, et al. Unravelling the intra-familial correlations and heritability of tumor types in MEN1, a GTE study (Groupe d’étude des Tumeurs endocrines). Eur J Endocrinol. 2015;173(6):819–26.CrossRef Thevenon J, Bourredjem A, Faivre L, Cardot-Bauters C, Calender A, Le Bras M, et al. Unravelling the intra-familial correlations and heritability of tumor types in MEN1, a GTE study (Groupe d’étude des Tumeurs endocrines). Eur J Endocrinol. 2015;173(6):819–26.CrossRef
Metadata
Title
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients
Authors
Francesca Marini
Francesca Giusti
Maria Luisa Brandi
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2018
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-018-0938-8

Other articles of this Issue 1/2018

Orphanet Journal of Rare Diseases 1/2018 Go to the issue